Skip to content

Study · Non-randomized trial · n = 76 · 2010

4 results

[Electrophysiological correlates of efficacy of nootropic drugs in the treatment of consequences of traumatic brain injury in adolescents].

The source lists no authors.

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2010

PMID20559264 (opens in a new tab)PepBankPUB-20559264
Publisher pageAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In adolescents with residual traumatic brain injury symptoms, positive brain functional dynamics occurred in 77% of patients with Cerebrolysin versus 50% of patients with piracetam and magne-B6.

    In plain wordsIn adolescents with residual brain injury symptoms, positive brain functional changes occurred in 77% with Cerebrolysin versus 50% with piracetam and magne-B6.

    Peptide
    Cerebrolysin
    Outcome
    IncreasePositive brain functional dynamics
    Study

    n = 76

    Comparator
    Piracetam and magne-B6 groups (50% reported for both together)
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated · one monthAs given in this study (human).

    Measurements

    Patients with positive brain functional dynamics
    77%
    Cerebrolysin
    Patients with positive brain functional dynamics
    50%
    Piracetam and magne-B6

    Source sentences

    Summary
    After the end of the nootropic therapy, 77% of patients treated with cerebrolysin as well as 50% of patients treated with piracetam and magne-B6 have demonstrated the positive dynamics of their brain functional state
    2 context sentences
    Summary · context
    The study included 76 adolescents, aged 12-18 years, who have undergone severe closed head trauma with brain commotion 1/2--5 years ago.
    Summary · context
    Patients have been divided into 3 groups treated during one month with cerebrolysin, piracetam or magne-B6, respectively.

Studies that did not test the peptide alone3

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 02HumanNot a test of Cerebrolysin aloneNon-randomized trialOther

    In adolescents receiving nootropic therapy including Cerebrolysin, positive neurophysiological changes were associated with improved clinical conditions.

    In plain wordsIn adolescents receiving nootropic therapy including Cerebrolysin, positive neurophysiological changes were linked to improved clinical conditions.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableClinical condition association with neurophysiological changes
    Study

    n: not reported in source

    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    Such positive changes of neurophysiological parameters have been associated with the improvement of clinical conditions of patients
    2 context sentences
    Summary · context
    The study included 76 adolescents, aged 12-18 years, who have undergone severe closed head trauma with brain commotion 1/2--5 years ago.
    Summary · context
    Patients have been divided into 3 groups treated during one month with cerebrolysin, piracetam or magne-B6, respectively.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  2. 03HumanNot a test of Cerebrolysin aloneNon-randomized trialOther

    In adolescents receiving nootropic therapy including Cerebrolysin, neurophysiological changes correlated significantly with changes in attention scores.

    In plain wordsIn adolescents receiving nootropic therapy including Cerebrolysin, neurophysiological changes were linked to changes in attention scores.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableAttention score correlation with neurophysiological changes
    Study

    n: not reported in source

    Outcome group
    Cognition and memory · Nervous system and cognition

    Source sentences

    Summary
    Such positive changes of neurophysiological parameters have been associated with the improvement of clinical conditions of patients and correlated significantly with the dynamics of psychometric scores of attention and memory.
    2 context sentences
    Summary · context
    The study included 76 adolescents, aged 12-18 years, who have undergone severe closed head trauma with brain commotion 1/2--5 years ago.
    Summary · context
    Patients have been divided into 3 groups treated during one month with cerebrolysin, piracetam or magne-B6, respectively.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  3. 04HumanNot a test of Cerebrolysin aloneNon-randomized trialOther

    In adolescents receiving nootropic therapy including Cerebrolysin, neurophysiological changes correlated significantly with changes in memory scores.

    In plain wordsIn adolescents receiving nootropic therapy including Cerebrolysin, neurophysiological changes were linked to changes in memory scores.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableMemory score correlation with neurophysiological changes
    Study

    n: not reported in source

    Outcome group
    Cognition and memory · Nervous system and cognition

    Source sentences

    Summary
    Such positive changes of neurophysiological parameters have been associated with the improvement of clinical conditions of patients and correlated significantly with the dynamics of psychometric scores of attention and memory.
    2 context sentences
    Summary · context
    The study included 76 adolescents, aged 12-18 years, who have undergone severe closed head trauma with brain commotion 1/2--5 years ago.
    Summary · context
    Patients have been divided into 3 groups treated during one month with cerebrolysin, piracetam or magne-B6, respectively.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.